Assertio Holdings, Inc.

Dr Reddy’s has announced the appointment of Milan Kalawadia as the firm’s CEO for North America, moving up from his previous position of chief commercial officer. Kalawadia – who will be based out of

Longboard Pharmaceuticals, Inc. ’s management offered some tidbits about its plans for a Phase III trial program of bexicaserin after the announcement of positive data from the Phase Ib/IIa PACIFIC tr

Assertio Holdings, Inc. is banking on a recently approved oncology drug from Spectrum Pharmaceuticals Inc. in its move to acquire that company for nearly a quarter of $1bn, while viewing it as a wa

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. OrsoBio Splurges With Four Concurrent L